BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT05558982 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05558982
- Sponsor
- Georgetown University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-16
- Primary completion
- 2025-12-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.